Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer

NCT04790682 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT04790682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04790682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Recruiting
Start date
May 22, 2021
Completion date
June 3, 2030
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic lung cancer